Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

6-Fluoro-DMT

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
6-Fluoro-DMT
Clinical data
Other names6-Fluoro-N,N-dimethyltryptamine; 6-Fluoro-DMT; 6-F-DMT; 6F-DMT
Drug classSerotonin receptor modulator;Serotonin 5-HT2A receptor agonist
ATC code
  • None
Identifiers
  • 2-(6-fluoro-1H-indol-3-yl)-N,N-dimethyl-ethanamine
CAS Number
PubChemCID
ChemSpider
UNII
Chemical and physical data
FormulaC12H15FN2
Molar mass206.264 g·mol−1
3D model (JSmol)
  • CN(CCC1=CNC2=C1C=CC(F)=C2)C
  • InChI=1S/C12H15FN2/c1-15(2)6-5-9-8-14-12-7-10(13)3-4-11(9)12/h3-4,7-8,14H,5-6H2,1-2H3 checkY
  • Key:DZXZPVGWRZCXDH-UHFFFAOYSA-N checkY
  (verify)

6-Fluoro-DMT, also known as6-fluoro-N,N-dimethyltryptamine, is aserotonin receptor modulator of thetryptamine family related todimethyltryptamine (DMT).[1][2]

Use and effects

[edit]

6-Fluoro-DMT was not included nor mentioned inAlexander Shulgin's bookTiHKAL (Tryptamines I Have Known and Loved).[3] However, he did briefly discuss it in an earlyliterature review, but its properties and effects in humans were not described.[1]

The closely related compound6-fluoro-DET has been found to be inactive in terms ofpsychedelic-type effects both in animals and humans.[4][5][6][3][7] Relatedly, it has been claimed that 6-fluoro-DMT is inactive as a psychedelic similarly to 6-fluoro-DET, though it is unclear whether this claim was based on actual testing or on extrapolation from 6-fluoro-DET and theoretical notions.[8] In the 1960s, it had been theorized byStephen Szára and colleagues that psychedelic tryptamines wereprodrugs that required 6-hydroxylation to become hallucinogenic, but this theory was later found to be incorrect.[9][10][11][12] Indeed, the related compound6-fluoro-AMT is known to be robustly active as a psychedelic.[13][14]

Pharmacology

[edit]

Pharmacodynamics

[edit]
6-Fluoro-DMT activities
TargetAffinity (Ki, nM)
5-HT1A693–865 (Ki)
IA (EC50Tooltip half-maximal effective concentration)
5-HT1B218
5-HT1D55
5-HT1E461
5-HT1FND
5-HT2A511–866 (Ki)
41–16,830 (EC50)
74% (
EmaxTooltip maximal efficacy)
5-HT2B30
5-HT2C674 (Ki)
1.252–5.816 (EC50)
105–131% (
Emax)
5-HT3>10,000
5-HT4ND
5-HT5A961
5-HT626
5-HT741
α1A173
α1B>10,000
α1DND
α2A>10,000
α2B260
α2C149
β1>10,000
β2>10,000
β3ND
D1547
D2610
D3867
D41,454
D56,291
H147
H2925
H3,H4>10,000
M1M5>10,000
I1898
σ16,892
σ27,128
TAAR1Tooltip Trace amine-associated receptor 1ND
SERTTooltip Serotonin transporter145 (Ki)
NETTooltip Norepinephrine transporter>10,000 (Ki)
DATTooltip Dopamine transporter>10,000 (Ki)
Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified.Refs:[15][2][16][17]

6-Fluoro-DMT is known to possess varyingaffinities forserotonin receptors,adrenergic receptors,dopamine receptors,histamine receptors, theimidazolineI1 receptor,sigma receptors, and theserotonin transporter (SERT).[2] It has been found to be apotentpartial agonist of theserotonin5-HT2A receptor and a potentfull agonist of the serotonin5-HT2C receptor.[2] In another study however, it showed affinity for the serotonin 5-HT1A and 5-HT2A receptors but was inactive as a serotonin 5-HT1A receptor agonist and showed low potency as a serotonin 5-HT2A receptor agonist.[16][17] On the other hand, it was only about 3-fold less potent thandimethyltryptamine (DMT) as a serotonin 5-HT2A receptor agonist in this study.[17] 6-Fluoro-DMT is less active thandimethyltryptamine (DMT) in producing effects inanimal studies.[1][18]

Chemistry

[edit]

Analogues

[edit]

Analogues of 6-fluoro-DMT include4-fluoro-DMT,5-fluoro-DMT,5-fluoro-AMT,5-bromo-DMT,5-chloro-DMT,bretisilocin (5-fluoro-MET),6-fluoro-AMT, and6-fluoro-DET, among others.

History

[edit]

6-Fluoro-DMT was first described in thescientific literature by at least 1966.[1][18][8]

See also

[edit]

References

[edit]
  1. ^abcdShulgin AT (1976). "Psychotomimetic Agents". In Gordon M (ed.).Psychopharmacological Agents: Use, Misuse and Abuse. Medicinal Chemistry: A Series of Monographs. Vol. 4. Academic Press. pp. 59–146.doi:10.1016/b978-0-12-290559-9.50011-9.ISBN 978-0-12-290559-9.This metabolically available site (6 position) was blocked with a fluoro-group in a number of these N,N-dialkyltryptamines. 6-Fluoro-N,N-dimethyltryptamine [(XXXVI), R = CH3] was again found to be less active than the parent N,N-dimethyltryptamine in animal studies (Kalir and Szara, 1966). However, clinical studies with the ethyl homolog [(XXXVI), R = C2H5] has shown that it produces most of the somatic effects of the comparison drug N,N-dipropyltryptamine without any of the psychological changes. It is proposed as an "active placebo" in controlling experiments with possible hallucinogenics (Faillace et al., 1967). The present evidence indicates that chemical substitution on the 6 position of the tryptamine system destroys the psychotomimetic potential of the compound.
  2. ^abcdRay TS (February 2010)."Psychedelics and the human receptorome".PLOS ONE.5 (2) e9019.Bibcode:2010PLoSO...5.9019R.doi:10.1371/journal.pone.0009019.PMC 2814854.PMID 20126400.
  3. ^abShulgin A,Shulgin A (September 1997).TiHKAL: The Continuation.Berkeley, California:Transform Press.ISBN 0-9630096-9-9.OCLC 38503252.
  4. ^Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, et al. (2023)."Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential".Nature Communications.14 (1): 8221.doi:10.1186/s12969-023-00927-3.PMC 10694965.PMID 38001451.
  5. ^"Psychedelic-Inspired Medium-Throughput Assays for the Development of Next-Generation Neurotherapeutics".ProQuest.6-F-DMT has been thought to be non-hallucinogenic as 6-F-DET (6-fluoro-N,N-diethyltryptamine) has been shown to not substitute for LSD in DD.
  6. ^"Fluorinated tryptamine compounds, analogues thereof, and methods using same".Google Patents. 2 June 2022. Retrieved8 April 2025.
  7. ^Faillace LA, Vourlekis A, Szara S (October 1967). "Clinical evaluation of some hallucinogenic tryptamine derivatives".J Nerv Ment Dis.145 (4):306–313.doi:10.1097/00005053-196710000-00005.PMID 6076017.
  8. ^abKline TB (1980).Structure-Activity Relationships Of N,N-Dialkyltryptamines Substituted In The Benzene Moiety.All ETDs from UAB (Ph.D. thesis). University of Alabama at Birmingham. Retrieved15 November 2024 – via UAB Digital Commons.Neither 6-hydroxy DMT, 5-methoxy-6-hydroxy DMT, nor the metabolically blocked 6-fluoro DMT are active hallucinogens in man.
  9. ^Szara S, Hearst E (1962)."The 6-Hydroxylation of Tryptamine Derivatives: A Way of Producing Psychoactive Metabolites".Annals of the New York Academy of Sciences.96 (1):134–141.Bibcode:1962NYASA..96..134S.doi:10.1111/j.1749-6632.1962.tb50108.x.ISSN 0077-8923. Retrieved8 April 2025.
  10. ^Szara S, Hearst E, Putney F (1962)."Metabolism and behavioural action of psychotropic tryptamine homologues".International Journal of Neuropharmacology.1 (1–3):111–117.doi:10.1016/0028-3908(62)90015-1. Retrieved8 April 2025.
  11. ^Szara S, Rockland LH, Rosenthal D, Handlon JH (September 1966). "Psychological effects and metabolism of N,N-diethyltryptamine in man".Arch Gen Psychiatry.15 (3):320–329.doi:10.1001/archpsyc.1966.01730150096014.PMID 5330062.
  12. ^Taborsky RG, Delvigs P, Page IH (August 1966). "6-hydroxylation: effect on the psychotropic potency of tryptamines".Science.153 (3739):1018–1020.Bibcode:1966Sci...153.1018T.doi:10.1126/science.153.3739.1018.PMID 5917552.
  13. ^Morris H (2010)."Life is a Cosmic Giggle on the Breath of the Universe. A Tour of Gordon Todd Skinner's Subterranean LSD Palace".Vice Magazine.Archived from the original on 2014-10-13. Retrieved2017-08-23.{{cite web}}: CS1 maint: overridden setting (link)
  14. ^"Unusual Analogues: Drugs Used by Gordon Todd Skinner".thislandpress.com. This Land Press. Archived fromthe original on 17 April 2016. Retrieved8 April 2016.
  15. ^"Kᵢ Database".PDSP. 22 March 2025. Retrieved22 March 2025.
  16. ^abChen X, Li J, Yu L, Maule F, Chang L, Gallant JA, et al. (October 2023)."A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines".J Biol Chem.299 (10) 105231.doi:10.1016/j.jbc.2023.105231.PMC 10570959.PMID 37690691.
  17. ^abcChen X, Li J, Yu L, Dhananjaya D, Maule F, Cook S, et al. (10 March 2023),Bioproduction platform using a novel cane toad (Rhinella marina) N-methyltransferase for psychedelic-inspired drug discovery(PDF),doi:10.21203/rs.3.rs-2667175/v1, retrieved18 March 2025
  18. ^abKalir A, Szara S (May 1966)."Synthesis and pharmacological activity of alkylated tryptamines"(PDF).J Med Chem.9 (3):341–344.doi:10.1021/jm00321a017.PMID 5960901.

External links

[edit]
Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
H1
Agonists
Antagonists
H2
Agonists
Antagonists
H3
Agonists
Antagonists
H4
Agonists
Antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=6-Fluoro-DMT&oldid=1323779191"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp